Kayan Ventures

We’re thrilled to announce that our portfolio company, Oxford Medical Products(OMP), has achieved a significant breakthrough in their clinical trials. Their innovative, non-surgical weight-loss pill demonstrated no adverse effects in the latest study, with participants losing up to 10% of their body weight in just 12 weeks! 🌟 The randomized controlled trial enrolled 40 adults with a BMI between 30-41, testing OMP’s pill, Sirona, against a placebo over 12 weeks. We’re proud to report that no serious adverse events occurred, and not a single participant withdrew due to product-related issues. As Dr. Camilla Easter, CEO of OMP, stated: “With over 8,000 doses delivered and our fantastic safety profile, Sirona is uniquely positioned to disrupt the overweight and obesity treatment market.” Read more here - https://lnkd.in/dFVRFS7e Huge congratulations to the OMP team! 🎉 Onward and upward!

Excited to announce Kayan Ventures' participation in Nevoya's latest funding round! Nevoya is breaking barriers in EV truck adoption, addressing key challenges in charging infrastructure. We're proud to support Sami Khan and the team in their push towards a more sustainable future in transportation. https://lnkd.in/dEHPQHCg

Scott Fulbright and Stevan Albers, co-founders of Kayan Ventures Portfolio company Living Ink , have been selected by Vogue Business as one of the 100 Innovators in Sustainability! Read the full article here - https://lnkd.in/gBtqa5eM

Exciting news for Mitra Chem Mitra Chem, a Kayan Ventures portfolio company, has been awarded a massive $100 million grant by the U.S. Department of Energy, in addition to $25 million grant from the state of Michigan, for domestic battery manufacturing! 🔋⚡ This grant marks a significant milestone in their journey to revolutionize battery materials and foster a sustainable, homegrown supply chain. Congratulations to the entire team at Mitra Chem on this extraordinary achievement Vikas Kante Vivas Kumar ! https://lnkd.in/gY9HPqwK

Kayan Ventures is incredibly proud of the accomplishments of one of our portfolio companies, Vytalize Health Health. The company has just been named the fastest-growing private company in America by Inc. Magazine Magazine! This recognition is a testament to the team’s relentless dedication to transforming healthcare and delivering exceptional value to patients and providers. We're honored to be part of Vytalize Health's journey and look forward to seeing what’s next for this incredible company. What an accomplishment by Faris Ghawi & Amer Alnajar and the entire Vytalize team and family. https://lnkd.in/eSfFY8Aq

Kayan Ventures is thrilled to announce its participation in the recent funding round for BoobyBiome, a groundbreaking company revolutionizing infant gut microbiome health through innovative synbiotic research. With the recent £1.6M grant from Innovate UK’s Biomedical Catalyst, BoobyBiome is poised to make significant strides in advancing gut health for newborns. We’re proud to support such a visionary team dedicated to improving lives from the very beginning. Stay tuned as we continue to back pioneering innovations in health! https://lnkd.in/ev58aTt8 Dr. Sioned Fôn Jones Lydia Mapstone, PhD Tara O'Driscoll, PhD

Exciting update from one of our portfolio companies Oxford Medical Products, as the last patient in their phase 2a trials begins their first dose.

Two of our portfolio companies have recently clinched 1st place awards by the National Renewable Energy Laboratory at their Investor Growth Forum. - Living Ink placed first in the “Outstanding Venture in the Breaking Ground/Production-Stage Pilots” - Mitra Chem placed first in the “Outstanding Venture in the Commercialization Stage” Congratulations to Scott Fulbright, Stevan Albers, Vikas Kante and Vivas Kumar on their achievements and for building truly unique and impactful companies. https://lnkd.in/dv377VJs

A great piece in the Financial Times on the flagship product of Living Ink , Algae Black (a Kayan Ventures portfolio company). In 2023 and YTD '24, Scott Fulbright and Stevan Albers have made huge strides with the company. In addition to being granted two patents, they have also continued demonstrating the success of their solutions in the marketplace, striking deals with Nike, Coach, New Balance, Patagonia and others. https://lnkd.in/ebJqtg6U

We're thrilled to see one of our portfolio companies and earlier investments at Kayan Ventures on stage at LEAP in Riyadh, a day after they installed the first huupe Pro int he region at Saudi's aramco headquarters in Al Khobar, KSA. Kayan was one of the main investors in Huupe's Seed Round and continues to be bullish on what this company can achieve for the sport of basketball and beyond. Looking forward to Huupe's leap into the next phase of its journey. Great job Lyth Saeed & Paul Anton. #sportstech #AI #machinelearning #innovation #basketball #leap2024